209 related articles for article (PubMed ID: 22398706)
1. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
[TBL] [Abstract][Full Text] [Related]
2. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality.
Nordal RR; Thoresen SO
Eur J Cancer; 1997 May; 33(6):907-11. PubMed ID: 9291814
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
Gao Y; Meng H; Zhang Y; Jiao T; Hui N
Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
[TBL] [Abstract][Full Text] [Related]
4. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
5. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
6. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
7. Improved long-term survival of corpus cancer in Japan: A 40-year population-based analysis.
Yagi A; Ueda Y; Ikeda S; Miyoshi A; Nakagawa S; Hiramatsu K; Kobayashi E; Kimura T; Ito Y; Nakayama T; Nakata K; Morishima T; Miyashiro I; Kimura T
Int J Cancer; 2022 Jan; 150(2):232-242. PubMed ID: 34494658
[TBL] [Abstract][Full Text] [Related]
8. Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study.
Boll D; Karim-Kos HE; Verhoeven RH; Burger CW; Coebergh JW; van de Poll-Franse LV; van Doorn HC
Eur J Obstet Gynecol Reprod Biol; 2013 Feb; 166(2):209-14. PubMed ID: 23176760
[TBL] [Abstract][Full Text] [Related]
9. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
[TBL] [Abstract][Full Text] [Related]
10. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
Rauh-Hain JA; Hariton E; Clemmer J; Clark RM; Hall T; Boruta DM; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Jun; 125(6):1362-1370. PubMed ID: 26000507
[TBL] [Abstract][Full Text] [Related]
11. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies on uterine carcinosarcoma, leiomyosarcoma, and endometrial stromal sarcoma: expression and prognostic importance of ten different markers.
Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
Tumour Biol; 2011 Jun; 32(3):451-9. PubMed ID: 21161468
[TBL] [Abstract][Full Text] [Related]
13. Survival of gynecological cancers in Turkey: where are we at?
Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of uterine corpus cancer in some cancer registering areas of China from 2003 - 2007].
Wei KR; Chen WQ; Zhang SW; Zheng RS; Wang YN; Liang ZH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):445-51. PubMed ID: 22932112
[TBL] [Abstract][Full Text] [Related]
15. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
Page BR; Pappas L; Cooke EW; Gaffney DK
Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
[TBL] [Abstract][Full Text] [Related]
16. Endometrioid endometrial adenocarcinoma: an increase of G3 cancers?
Mang C; Birkenmaier A; Cathomas G; Humburg J
Arch Gynecol Obstet; 2017 Jun; 295(6):1435-1440. PubMed ID: 28421274
[TBL] [Abstract][Full Text] [Related]
17. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.
Huang CY; Chen CA; Chen YL; Chiang CJ; Hsu TH; Lin MC; Lai MS; Chen CJ; You SL; Cheng WF
PLoS One; 2012; 7(12):e51372. PubMed ID: 23251510
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of fallopian tube cytology: a study of 99 endometrial malignancies.
Mulvany NJ; Arnstein MB; Ryan VA
Pathology; 2000 Feb; 32(1):5-9. PubMed ID: 10740797
[TBL] [Abstract][Full Text] [Related]
19. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]